Tissue types.
Skip to search form Skip to main content You are currently offline. Some features of the site may not work correctly. DOI: Collen and H. CollenH.
GET HELP WITH THIS ASSIGNMENT TODAY
View on Wiley. Save to Library. Create Alert. Launch Research Feed. Share This Paper. Background Citations.
Methods Citations. Topics from this paper. Citation Type. Has PDF. Publication Type.
Tissue membranes
More Filters. A novel role for tissue-type plasminogen activator: prevention of thromboembolic occlusion.
Research Feed. View 1 excerpt, cites background. Translational initiatives in thrombolytic therapy. Thrombolytic Therapy Targeting Alpha 2-Antiplasmin. Tissue plasminogen activator therapy for the eye.
Expert Answer
Recombinant Coagulation Factors and Thrombolytic Agents. The evolution Tissue types recombinant thrombolytics: Current status and future directions. Highly Influenced. View 3 excerpts, cites background. Elevated tissue plasminogen activator in patients with screening-detected abdominal aortic aneurysm. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus. Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. Improved Is Your Ign with a modified dose regimen of recombinant tissue-type plasminogen activator. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in Tissue types cells. Coronary thrombolysis with recombinant human tissue-type plasminogen activator. Relationship between tissue plasminogen activator and the activators in blood and vascular wall. Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.]
I apologise, but, in my opinion, you are not right. I am assured. I can prove it. Write to me in PM, we will communicate.
I apologise, but, in my opinion, you are mistaken. Let's discuss. Write to me in PM.